Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

Similar documents
B Cell Generation, Activation & Differentiation. B cell maturation

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

B Cells and Antibodies

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

B cell activation and Humoral Immunity

Microbiology AN INTRODUCTION EIGHTH EDITION

Chapter 5: Organization and Expression of Immunoglobulin Genes

Why discuss CLL? Common: 40% of US leukaemia. approx 100 pa in SJH / MWHB 3 inpatients in SJH at any time

Activation and effector functions of HMI

2) Macrophages function to engulf and present antigen to other immune cells.

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

The Immune System: A Tutorial

Antibody Structure, and the Generation of B-cell Diversity CHAPTER 4 04/05/15. Different Immunoglobulins

B Lymphocyte (B cell)

Recognition of T cell epitopes (Abbas Chapter 6)

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

How do plasma cells survive

T Cell Maturation,Activation and Differentiation

Basics of Immunology

Dendritic Cells: A Basic Review *last updated May 2003

Name (print) Name (signature) Period. (Total 30 points)

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Multiple Myeloma and Colorectal Cancer

Guidance for Industry

Immunology. B lymphocytes & Antibodies , Ruhr-Universität Bochum Marcus Peters, marcus.peters@rub.de

Analysis and Integration of Big Data from Next-Generation Genomics, Epigenomics, and Transcriptomics

Molecular characterization of human bone marrow stromal cells supporting early B lymphopoiesis.

Cytotoxic T Lymphocytes (CTLs) and NK Cells. Effector T cells. After activation, naïve T cells differentiate into effector and memory T cells

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

Chapter 43: The Immune System

Chapter 18: Applications of Immunology

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

How To Expand Hematopoietic Stem Cells


The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small

Antibody Function & Structure

Antigens & Antibodies II. Polyclonal antibodies vs Monoclonal antibodies

CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

Chapter 3. Immunity and how vaccines work

Understanding the Immune System in Myeloma

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

Immunity. Humans have three types of immunity innate, adaptive, and passive: Innate Immunity

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

The Case of Baby Joe by Kristen L.W. Walton Page 1

Next generation sequencing and proteomics. to study the antibody repertoire. and generate monoclonal antibodies

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Staph Protein A, Immune Complexes, Cryoglobulins, and the Treatment of Rheumatoid Arthritis:

TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS.

Core Topic 2. The immune system and how vaccines work

Malignant Lymphomas and Plasma Cell Myeloma

Plasma Cells. Introduction. Development, Differentiation and Migration. Advanced article. Plasma cell morphology

Problem Set 6 KEY

Essentials in Immunology Prof. R. Manjunath Department of Biochemistry Indian Institute of Science, Bangalore

Chapter 2 Antibodies. Contents. Introduction

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense

Immune System Memory Game

THE HUMORAL IMMUNE SYSTEM

Too Many B Cells: Chronic Lymphocytic Leukemia and the Role of Flow Cytometry

Making the switch to a safer CAR-T cell therapy

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System

Analysis of the colorectal tumor microenvironment using integrative bioinformatic tools

Types, production of antibodies and Antibody/antigen interaction

7.012 Quiz 3 practice

Chimeric Antigen Receptor T Cell Therapy

B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: Lessons Learned from Studies of the B Cell Antigen Receptor

Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms. Dr. Douaa Mohammed Sayed

PROGRAMM. 1. Forum Biologie der B- Lymphozyten" Tagungsstätte: in Titisee März, 2002

Autoimmunity and immunemediated. FOCiS. Lecture outline

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

The Body s Defenses CHAPTER 24

The Use of Antibodies in Immunoassays

Exercise 9: Blood. Readings: Silverthorn 5 th ed, , ; 6 th ed, ,

Analyzing antibody sequence for recombinant antibody expression. Hangxing Yu, Ph.D Senior Scientist, GenScript May 20, 2015

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO Gundersen Health System Center for Cancer and

ELISA BIO 110 Lab 1. Immunity and Disease

ELITE Custom Antibody Services

SUMMARY AND CONCLUSIONS

An Introduction to Stem Cell Biology. Michael L. Shelanski, MD,PhD Professor of Pathology and Cell Biology Columbia University

Investigation of B cell malignancies. Dr. Joanna Sheldon Protein Reference Unit St. George s s Hospital

Immunoglobulin diversity, B-cell end antibody repertoire development in large farm animals

CHAPTER 6 ANTIBODY GENETICS: ISOTYPES, ALLOTYPES, IDIOTYPES

Human CD4+T Cell Care Manual

Chapter 16: Innate Immunity

3 rd B Cell Forum March 17 to 19, 2005 Bad Breisig, Germany Germany. Germany

A novel molecular mechanism involved in cancer development revealed by targeting MafB to hematopoietic progenitors

An Artificial Immune System for Misbehavior Detection in Mobile Ad-Hoc Networks with Virtual Thymus, Clustering, Danger Signal and Memory Detectors

HuCAL Custom Monoclonal Antibodies

A Web-Based Antibody Database Page1. A Web-Based Antibody Database. Thesis Proposal. For the degree of Master of Science in Computer Science

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Effector Mechanisms of Humoral Immunity

Frequency Of Autoreactive T Cells 3/5/2014. Circulation Of Activated Cells To The CNS

Leukemias and Lymphomas: A primer

Immune Basis of New MS Therapies

Transcription:

Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells

Key anatomical sites Embryo/fetus aorta-gonad-mesonephros (AGM) Yolk sac Fetal liver Adult Bone marrow - primary, B2 B Lymph node, Spleen - secondary, B2 B Fetal liver & adult peritoneal cavity - B1 B cells

Hematopoiesis myeloid lymphoid Required transcription factors PU.1 ikaros E2A EBF pax5

Key transcription factors in lineage fate commitment lymphoid vs myeloid PU.1 - graded levels lineage fate; controls IL7R and CD45R/B220 ikaros - stem cell renewal, TdT VpreB λ5 lymphoid - B lineage differentiation E2A - initiates a transcriptional hierarchy; ebf, rag expression, λ5, mb-1 EBF - pax5, VpreB, λ5 pax5 (BSAP) - CD19, V-DJ joining (accessibility), blnk

PU.1 lineage fate decisions graded expression mediates lineage fate decisions Science (2000) 288:1439

Transcriptional hierarchy int PU.1 lo/- eryth progenitor

pax5 suppresses alternative fates Nature (1999) 401:556 Pro B: D-J No V-DJ VpreB λ5 macrophage granulocyte osteoclasts

Lineage fate determination Binary Plastic (simplified) M-CSF fms myeloid NK Meg my HSC DC HSC B IL-7 rag B E Gr T Commitment is plastic NOT binary Transcription factors regulate suites of genes on/off So, when is a cell committed??

Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors Cobaleda et al. (2007) Nature 449:473

pax5 deletion leads to cancer

Key surface markers

Conditional deletion of pax5

Mature IgM + IgD + B cells give rise to T cells on loss of pax5

polyclonal T cells derive from oligoclonal B cells

B cells turned T cells have normal T cell function

Loss of the transcription factor Pax5 leads to dedifferentiation of committed mature B cells

Biological sig?: Reed-Sternberg cells in Hodgkin Lymphoma phenotype: rearranged BCR somatic hypermutation ~30% CD20 small proportion CD45 variable CD19 lack: CD79a/mb-1 CD79b/B29 associated signaling molecules can possess: CD15 (granulocytes) CD30 (T cells) perforin

Conventional B2 B cells: The first checkpoint Before antigen 1 2 3 4 5 6 7 8 9 10 ~50 x 10 6 produced/day After antigen 10 only 10% enter periphery Figure 11-1

Different stromal cells provide different microenvironments life in 3D Blood (1999) 93:140

The developmental microenvironment Two kinds of support 1. cell adhesion molecules ex. VCAM 2. cytokines ex. IL-7, soluble ex. SCF, membrane bound Changes during development 1. surface: CD19, CD20, CD45 2. inside: signal transducers ex. lyn, blk, fyn transcription factors ex. E2A, EBF ~Nurse Cells

Selection of productive rearrangements rag expression

Pre B cell receptor B CELL STAGE stem cell early pro-b late pro-b pre-b IgH gene config. germline D H to J H V H to DJ H VDJ H IgL gene config. germline germline germline germline Ig light chain gene has not yet rearranged So what s paired with heavy chain?

Surrogate light chains VpreB is a V-like region λ5 is a C-like region

STAGES of PRODUCTION (B2) 1. generation 2. elimination of self-reactive B cells 3. activation by antigen 4. differentiation

Elimination of self-reactive B cells H-2 d transgenics production of mature anti-k k B cells

Elimination of self-reactive B cells Clonal Deletion

Option 2: Receptor Editing

Receptor Editing rag rag can be re-upregulated light chain ONLY undergoes new VJ recombination

Option 3: Anergy µ + in anergy, IgM is retained inside cell

Elimination of self-reactive B cells in bone marrow 1. Clonal deletion (apoptosis) 2. Receptor editing 3. Anergy

What happens if Ag expressed only in periphery

clonal deletion (note: in this case, K b antigen is expressed only in liver)

Autoreactive B cell bone marrow: clonal deletion (apoptosis) receptor editing anergy periphery: clonal deletion (apoptosis) anergy

Cutting Edge of Immunology: B1 B cells mature and reside in distinct physiological locations relative to B2 secrete mostly IgM do not require IL-7 required for containment of Borrelia B2 cannot compensate for loss of B1

Relapsing Hemorrhagic Fever (Borrelia hermsii) American Museum of Natural History http://research.amnh.org/ http://www.radio.cbc.ca/programs/ideas/shows/bacteria/willy.html Pioneering work of Alugupalli et al. J. Immunol. (2003) 170:3819 & Immunity (2004) 21:379 (followed up by Haas et al. (2005) 23:7 with strep pneumoniae)

What cells clear the Borrelia infection? loss of function expt. wild-type mouse IL2Rγ (γc) knockout rag knockout

Role of T cells Bacteremia (mean ± SD) 37.9 ± 7.3 wild-type mouse 31.1 ± 15 (NS) TCRβ knockout 39.8 ± 8.6 (NS) TCRβxδ knockout

Role of B2 B cells wild-type IL-7 KO B2 B cells not required; it must be the B1 B cells (indirect proof)

It s the B1 B cells, stupid! gain of function expt. # bacteria/µl of blood (x10 3 ) rag knockout rag knockout + purified B1 B cells days post infection B1 B cells mediate clearance (gain of function study)

T-dependent vs T-independent responses Figure 11-6 isotype switching affinity maturation memory - - - + + +

B2 versus B1 B cells site of development B2 bone marrow B1 peritoneum IL-7 requirement Yes No antibody production reactivity role IgM to start, then active class switching complex proteins; multiple epitopes memory; antibodies of different functionality dominantly IgM (natural antibody) repeating polysaccharides rapid production of neutralizing antibodies

* *

Summary B1, B2, MZ cells distinct biological roles distinct developmental requirements different physiological locations possibly distinct precursors

Review lineage plasticity E2A, EBF, pax5 transcriptional cascade conventional (B2) B cell development surrogate light chains dealing with autoreactivity: clonal deletion, anergy, receptor editing B2 versus B1 B cells